Skip to main content

14.09.2023 | Editorial

Coffee drinking then and now: research continues to better understand this ubiquitous beverage

verfasst von: Murray Esler

Erschienen in: Clinical Autonomic Research

Einloggen, um Zugang zu erhalten

Excerpt

Coffee drinking has a long history. The first mention of the coffee bean is from Ethiopia, where it was eaten, rather than roasted, crushed, and brewed [ 1]. Coffee as a drink was first described in Yemen, consumed by Sufism religious observants to energize them for marathon episodes of praying [ 1]. The first described commercial plantations were also in Yemen, export of the beans to Egypt and Istanbul being through the port of Mocha. For a time, Istanbul was the unofficial world capital of coffee drinking. Coffee initially reached Europe with Ottoman military actions, and coffee drinking soon became an established custom in Germany, France, and England, flourishing in the coffee house trade [ 1]. Observers of the time in England, in the early seventeenth century, favorably compared coffee houses, with the taverns they partly replaced. The coffee houses were said to be characterized by civility and engaging discourse, the taverns by dulled wits, drunkenness, and violence. With time, the United States became the major world consumer, although coffee drinking is internationally ubiquitous. A morning Starbucks queue snaking across the pavement has become a visual emblem of US cities. It is perhaps surprising that after nearly five centuries of coffee drinking, there remain important gaps in the knowledge of the pharmacology and medical effects of coffee drinking. The manuscript by Jennifer Butler, David Jardin, and colleagues, from New Zealand [ 2], successfully addresses some of these deficiencies. …
Literatur
1.
Zurück zum Zitat Biderman B (2013) A people’s history of coffee and cafes. Black Apollo Press, London Biderman B (2013) A people’s history of coffee and cafes. Black Apollo Press, London
3.
Zurück zum Zitat Robertson D, Frolich JC, Carr RK, Watson JT, Hollifield JW, Shand DG et al (1978) Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med 298:181–186 CrossRefPubMed Robertson D, Frolich JC, Carr RK, Watson JT, Hollifield JW, Shand DG et al (1978) Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med 298:181–186 CrossRefPubMed
4.
Zurück zum Zitat Esler M, Meredith I (1992) Responses of the human sympathetic nervous system to stressors. In: Sheppard KE, Boublik JH, Funder JW (eds) Stress and reproduction, vol 86. Ares Symposium Publications, Raven Press, New York, pp 19–30 Esler M, Meredith I (1992) Responses of the human sympathetic nervous system to stressors. In: Sheppard KE, Boublik JH, Funder JW (eds) Stress and reproduction, vol 86. Ares Symposium Publications, Raven Press, New York, pp 19–30
5.
Zurück zum Zitat Smits P, Schouten J, Thien T (1989) Cardiovascular effects of two xanthines and the relation to adenosine antagonism. Clin Pharmacol Ther 45:593–599 CrossRefPubMed Smits P, Schouten J, Thien T (1989) Cardiovascular effects of two xanthines and the relation to adenosine antagonism. Clin Pharmacol Ther 45:593–599 CrossRefPubMed
7.
Zurück zum Zitat American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (DSM-5). American Psychiatric Association (APA) CrossRef American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (DSM-5). American Psychiatric Association (APA) CrossRef
11.
Zurück zum Zitat Thomopoulos C, Parati G, Zanchetti A (2014) Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials. J Hypertens 32:2285–2295 CrossRefPubMed Thomopoulos C, Parati G, Zanchetti A (2014) Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials. J Hypertens 32:2285–2295 CrossRefPubMed
18.
Zurück zum Zitat Esler M, Lambert G, Schlaich M, Dixon J, Sari E, Lambert E (2018) Obesity Paradox in hypertension. Is this because sympathetic activation in obesity-hypertension takes a benign form? Hypertension 71:22–33 CrossRefPubMed Esler M, Lambert G, Schlaich M, Dixon J, Sari E, Lambert E (2018) Obesity Paradox in hypertension. Is this because sympathetic activation in obesity-hypertension takes a benign form? Hypertension 71:22–33 CrossRefPubMed
Metadaten
Titel
Coffee drinking then and now: research continues to better understand this ubiquitous beverage
verfasst von
Murray Esler
Publikationsdatum
14.09.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Autonomic Research
Print ISSN: 0959-9851
Elektronische ISSN: 1619-1560
DOI
https://doi.org/10.1007/s10286-023-00981-7

Neu in den Fachgebieten Neurologie und Psychiatrie